Involvement of dipeptidyl peptidase IV in immune complex-mediated glomerulonephritis

Laboratory Investigation

Volumn 82, Issue 4, 2002, Pages 505-513

  Shinosaki, Toshihiro ^a   Kobayashi, Tatsuo ^a   Kimura, Kazuhiro ^a   Kurihara, Hidetake ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; IMMUNE COMPLEX NEPHRITIS; IMMUNE SYSTEM; KIDNEY INJURY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT STRAIN;

EID: 0036227801     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780443     Document Type: Article

References (39)

1. Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis
2. Functional role of CD26 on human B lymphocytes
3. Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells
4. Role of C5b-9 in experimental membranous nephropathy
5. CD26, let it cut or cut it down
6. A novel form of dipeptidylpeptidase IV found in human serum: Isolation, characterization, and comparison with T lymphocyte membrane dipeptidylpeptidase IV (CD26)
7. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. I. The natural history: A histologic and immunohistologic study at the light microscopy and the ultrastructural level
8. The role of complement system in renal injury
9. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions
10. A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities
11. A new dipeptide naphthylamidase hydrolyzing glycyl prolyl-beta-naphthylamide
12. CD26/ dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: Possible mechanism for the switch from innate to acquired immune response
13. Involvement of complement components in renal disease
14. Monoclonal antibody P-31 recognizes a novel intermediate filament-associated protein (p250) in rat podocytes
15. Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation
16. I. Induction of proteinuria in the rat by a monoclonal antibody against SGP-115/107
17. Increased population of high fluorescence 1 F7 (CD26) antigen on T cells in synovial fluid of patients with rheumatoid arthritis
18. The structure and function of CD26 in the T-cell immune response
19. 1F7, A novel cell surface molecule, involved in helper function of CD4 cells
20. The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis
21. Transfected CD59 protects mesangial cells from injury induced by antibody and complement
22. Overexpression of Crry protects mesangial cells from complement-mediated injury
23. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108
24. Identification of gp108, a pathogenic antigen for experimental immune complex glomerulonephritis, as dipeptidyl peptidase IV
25. Role of dipeptidyl peptidase IV (gp108) in passive Heymann nephritis: Use of dipeptidyl peptidase IV-deficient rats
26. Primary structure of rat liver dipeptidyl peptidase IV deduced from its cDNA and identification of the NH2-terminal signal sequence as the membrane-anchoring domain
27. Purification and properties of glycylprolyl-naphthylamidase in human submaxillary gland
28. Transgenic mice overexpressing the complement inhibitor Crry as a soluble protein are protected from antibody-induced glomerular injury
29. Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-β1 in PWM-stimulated PBMC and T cells
30. Dipeptidyl peptidase IV (CD26) on human lymphocytes: Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 production
31. Glomerular epithelial cell injury accelerates the progression of antibody-induced mesangial proliferative nephritis
32. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-β1 secretion in vivo
33. An amphiphilic form of dipeptidyl peptidase IV from pig small-intestinal brush-border membrane: Purification by immunoadsorbent chromatography and some properties
34. Hydrolysis and transport of proline-containing peptides in renal brush-border membrane vesicles from dipeptidyl peptidase IV-positive and dipeptidyl peptidase IV-negative rat strains
35. Some statistical methods useful in circulation research
36. Deficiency of membrane-bound dipeptidyl aminopeptidase IV in a certain rat strain
37. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis
38. Clusterin is up-regulated in glomerular mesangial cells in complement-mediated injury
39. Complement dependence of antibody-induced mesangial cell injury in the rat